196 related articles for article (PubMed ID: 35427454)
21. Therapeutic potential of salicylamide derivatives for combating viral infections.
Xu J; Xue Y; Bolinger AA; Li J; Zhou M; Chen H; Li H; Zhou J
Med Res Rev; 2023 Jul; 43(4):897-931. PubMed ID: 36905090
[TBL] [Abstract][Full Text] [Related]
22. Structure Properties and Mechanisms of Action of Naturally Originated Phenolic Acids and Their Derivatives against Human Viral Infections.
Wu YH; Zhang BY; Qiu LP; Guan RF; Ye ZH; Yu XP
Curr Med Chem; 2017; 24(38):4279-4302. PubMed ID: 28814240
[TBL] [Abstract][Full Text] [Related]
23. 5-Membered Heterocyclic Compounds as Antiviral Agents.
Tratrat C; Petrou A; Fesatidou M; Haroun M; Athina G; Venugopala K; Sreeharsha N; Chemali J
Curr Top Med Chem; 2023; 23(7):520-538. PubMed ID: 37254567
[TBL] [Abstract][Full Text] [Related]
24. Design and synthesis of novel Imidazo[2,1-b]thiazole derivatives as potent antiviral and antimycobacterial agents.
Gürsoy E; Dincel ED; Naesens L; Ulusoy Güzeldemirci N
Bioorg Chem; 2020 Jan; 95():103496. PubMed ID: 31862455
[TBL] [Abstract][Full Text] [Related]
25. Antiviral activities of flavonoids.
Badshah SL; Faisal S; Muhammad A; Poulson BG; Emwas AH; Jaremko M
Biomed Pharmacother; 2021 Aug; 140():111596. PubMed ID: 34126315
[TBL] [Abstract][Full Text] [Related]
26. Host-targeted nitazoxanide has a high barrier to resistance but does not reduce the emergence or proliferation of oseltamivir-resistant influenza viruses in vitro or in vivo when used in combination with oseltamivir.
Tilmanis D; Koszalka P; Barr IG; Rossignol JF; Mifsud E; Hurt AC
Antiviral Res; 2020 Aug; 180():104851. PubMed ID: 32544408
[TBL] [Abstract][Full Text] [Related]
27. Synthesis and antiviral activity of some new bis-1,3-thiazole derivatives.
Dawood KM; Eldebss TM; El-Zahabi HS; Yousef MH
Eur J Med Chem; 2015 Sep; 102():266-76. PubMed ID: 26291036
[TBL] [Abstract][Full Text] [Related]
28. Antiviral drugs for viruses other than human immunodeficiency virus.
Razonable RR
Mayo Clin Proc; 2011 Oct; 86(10):1009-26. PubMed ID: 21964179
[TBL] [Abstract][Full Text] [Related]
29. Antivirals: past, present and future.
De Clercq E
Biochem Pharmacol; 2013 Mar; 85(6):727-44. PubMed ID: 23270991
[TBL] [Abstract][Full Text] [Related]
30. Antiviral Activities of Pyridine Fused and Pyridine Containing Heterocycles, A Review (from 2000 to 2020).
Alizadeh SR; Ebrahimzadeh MA
Mini Rev Med Chem; 2021; 21(17):2584-2611. PubMed ID: 33573543
[TBL] [Abstract][Full Text] [Related]
31. Recent patents on nucleoside and nucleotide inhibitors for HCV.
Shim JH; Hong Z; Wu JZ
Recent Pat Antiinfect Drug Discov; 2006 Nov; 1(3):323-31. PubMed ID: 18221157
[TBL] [Abstract][Full Text] [Related]
32. Antiviral activity of hop constituents against a series of DNA and RNA viruses.
Buckwold VE; Wilson RJ; Nalca A; Beer BB; Voss TG; Turpin JA; Buckheit RW; Wei J; Wenzel-Mathers M; Walton EM; Smith RJ; Pallansch M; Ward P; Wells J; Chuvala L; Sloane S; Paulman R; Russell J; Hartman T; Ptak R
Antiviral Res; 2004 Jan; 61(1):57-62. PubMed ID: 14670594
[TBL] [Abstract][Full Text] [Related]
33. [Advances in antiviral chemotherapy].
Baba M
Uirusu; 2005 Jun; 55(1):69-75. PubMed ID: 16308532
[TBL] [Abstract][Full Text] [Related]
34. Antiviral resistance and impact on viral replication capacity: evolution of viruses under antiviral pressure occurs in three phases.
Nijhuis M; van Maarseveen NM; Boucher CA
Handb Exp Pharmacol; 2009; (189):299-320. PubMed ID: 19048205
[TBL] [Abstract][Full Text] [Related]
35. Preclinical development of TLR ligands as drugs for the treatment of chronic viral infections.
Zhang X; Kraft A; Broering R; Schlaak JF; Dittmer U; Lu M
Expert Opin Drug Discov; 2012 Jul; 7(7):597-611. PubMed ID: 22607384
[TBL] [Abstract][Full Text] [Related]
36. 2,4,5-Trisubstituted Thiazole: A Privileged Scaffold in Drug Design and Activity Improvement.
Zhang Z; Shu B; Zhang Y; Deora GS; Li QS
Curr Top Med Chem; 2020; 20(28):2535-2577. PubMed ID: 32942975
[TBL] [Abstract][Full Text] [Related]
37. 5-(1-Substituted) alkyl pyrimidine nucleosides as antiviral (herpes) agents.
Kumar R
Curr Med Chem; 2004 Oct; 11(20):2749-66. PubMed ID: 15544474
[TBL] [Abstract][Full Text] [Related]
38. [Prospects and current data in antiviral chemotherapy].
Huraux JM; Ingrand D; Agut H; Devillechabrolle A
Rev Pneumol Clin; 1989; 45(3):99-105. PubMed ID: 2685967
[TBL] [Abstract][Full Text] [Related]
39. Antiviral therapeutics for chikungunya virus.
Ghildiyal R; Gabrani R
Expert Opin Ther Pat; 2020 Jun; 30(6):467-480. PubMed ID: 32249636
[No Abstract] [Full Text] [Related]
40. Overcoming drug resistance in HSV, CMV, HBV and HCV infection.
López-Labrador FX; Berenguer M; Navarro D
Future Microbiol; 2015; 10(11):1759-66. PubMed ID: 26522939
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
